Frequency of hepatocellular carcinoma in cirrhotic patients with hepatitis-C virus positive patients in Karachi-Pakistan
Keywords:HCV, Cirrhosis, Hepatocellular carcinoma, Alpha fetoprotein
Background: Hepatocellular Carcinoma is the 5th most common neoplasm in the world and 4th most common cancer death. Most patients with HCC have an underlying chronic liver disease (often cirrhosis), resulting mainly from chronic infection by Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), excessive alcohol consumption, and often an association of these causes. HCC has recently gained more interest due to its increasing incidence in industrialized countries. Objective: To determine the frequency of hepatocellular carcinoma in hepatitis C reactive cirrhotic patients.
Methods: Place and duration of study: Department of medicine, civil hospital Karachi. Duration: Six months from 16-12-2012 to 15-6-2013. Subjects and methods: Patients admitted in medical wards of civil hospital Karachi with liver cirrhosis due to hepatitis C virus were included in the study. Investigation relevant to hepatocellular carcinoma like alpha fetoprotein and ultrasound was performed. If the Alpha fetoprotein is greater, then 200 ng/ml in the setting of a mass in a cirrhotic liver the likelihood of hepatocellular carcinoma is greater then 90% and biopsy is not required.
Results: Overall mean age was 41.1 ± 7.1 years with Male:Female = 4.2:1. Out of 141 cases; hepatocellular carcinoma was diagnosed in 8 (5.7%) of patients with HCV related cirrhosis with mean age 48.6 ± 6.4 years. Proportion of hepatocellular carcinoma was high 7 (6.1%) in male. 7 (6.4%) cases had child pugh-C, 1 (5%) case had child pugh-B and while no HCC was seen in child pugh-A.
Conclusion: In this study hepatocellular carcinoma was 5.7% in cases with hepatitis-C induced cirrhosis. Older age (>54 years), male sex and child pugh-C were predominant factors leading to hepatocellular carcinoma.
Ali SA, Donahue RM, Qurashi H, Vermund SH. Hepatitis B and hepatitis C virus in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13:9-19.
Ahmad N, Asgher M, Shafique M, Qureshi JA. An evidence of high prevalence of hepatitis C virus in Faisalabad, Pakistan. Saudi Med J. 2007;28:390-5.
Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systemic review of prevalence, genotypes and risk factors. Wolrd J Gastroentrol. 2009;15:5647-53.
Trinchet JC, Ganne-Carrie N, Nahon P, Kontchou G, Beaugrand M. Hepatocellular carcinoma in patients with hepatitis C virus related chronic liver disease. Wolrd J Gastroentrol. 2007;13:2455-60.
Chohan AR, Umar M, Khaar B, Khurram M, Zahid M, Shah SF, et al. Demographic features of hepatocellular carcinoma. A study of 30 cases. J Rawal Med Coll. 2001;5:81-3.
Farooqi JI, Farooqi RJ. Prevalence of hepatocelllar carcinoma in patients of liver cirrhosis. J Coll Physicians Surg Pak. 2000;10:54-5.
Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:5-16.
Giordano TP, Kramer JR, Souchek J. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004;164:2349-54.
WHO. Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997;72:341-4.
Sharieff S, Burni I, Salim A, Siddiqui T. Hepatocellular carcinoma. J Coll Physicians Surg Pak. 2002;12:264-7.
Choo QL, Vinor AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus. The major causative agent of non-A non-B hepatitis. Br Med Bull. 1990;46:423-41.
Kew MC, Dos Santos HA, Sherlock S. Diagnosis of primary cancer of the liver. Br Med J. 1971;4:408.
The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;28:751-5.
Tietge UJ, Scholf C, Ocran KW, Wagner S, Böker KH, Brabant G, et al. Hepatoma with severe non-islet cell tumor hypoglycemia. Am J Gastroenterol. 1998;93:997-1000.
Sherman M. Chronic hepatitis and screening for hepatocellular carcinoma. Clin Liver Dis. 2006;10(4):735-52.
El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:74-83.
McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19:3-23.
Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143-54.
Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology. 1997;26:34-8.
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:35-50.
Ikeda K, Arase Y, Saitoh S, Kobayashi M, Someya T, Hosaka T, et al. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts. J Hepatol. 2006;44:1089-97.
Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37:520-7.
Paul SB, Sreenivas V, Gulati MS, Madan K, Gupta AK, Mukhopadhyay S, et al. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India. Indian J Gastroenterol. 2007;26:274-8.
Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L. Hepatocellular carcinoma in liver cirrhosis: a prospective study. Informa. 1993;28:540-4.
Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut. 2000;47:131-6.
Di Bisceglie AM, Carithers RL Jr, Gores GJ. Hepatocellular carcinoma. Hepatology. 1998;28:1161-5.